These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30790732)

  • 41. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of reproducibility in MRI quantitative volumetric assessment and its role in the prediction of overall survival and progression-free survival in glioblastoma.
    Blomstergren A; Rydelius A; Abul-Kasim K; Lätt J; Sundgren PC; Bengzon J
    Acta Radiol; 2019 Apr; 60(4):516-525. PubMed ID: 29966430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
    Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
    Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High IFIT1 expression predicts improved clinical outcome, and IFIT1 along with MGMT more accurately predicts prognosis in newly diagnosed glioblastoma.
    Zhang JF; Chen Y; Lin GS; Zhang JD; Tang WL; Huang JH; Chen JS; Wang XF; Lin ZX
    Hum Pathol; 2016 Jun; 52():136-44. PubMed ID: 26980050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is Edema Zone Volume Associated With Ki-67 Index in Glioblastoma Patients?
    Caramanti R; Aprígio RM; D Aglio Rocha CE; Morais DF; Góes MJ; Chaddad-Neto F; Tognola WA
    Cureus; 2022 Apr; 14(4):e24246. PubMed ID: 35602791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frontal glioblastoma multiforme may be biologically distinct from non-frontal and multilobar tumors.
    Paldor I; Pearce FC; Drummond KJ; Kaye AH
    J Clin Neurosci; 2016 Dec; 34():128-132. PubMed ID: 27593971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
    Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
    Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
    [No Abstract]   [Full Text] [Related]  

  • 48. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
    Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diffusion tensor and dynamic susceptibility contrast MRI in glioblastoma.
    Zikou AK; Alexiou GA; Kosta P; Goussia A; Astrakas L; Tsekeris P; Voulgaris S; Malamou-Mitsi V; Kyritsis AP; Argyropoulou MI
    Clin Neurol Neurosurg; 2012 Jul; 114(6):607-12. PubMed ID: 22266399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Co-expression of COX-2 and 5-LO in primary glioblastoma is associated with poor prognosis.
    Wang X; Chen Y; Zhang S; Zhang L; Liu X; Zhang L; Li X; Chen D
    J Neurooncol; 2015 Nov; 125(2):277-85. PubMed ID: 26334317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.
    Czarnek N; Clark K; Peters KB; Mazurowski MA
    J Neurooncol; 2017 Mar; 132(1):55-62. PubMed ID: 28074320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of Ki-67 index in primary intracranial tumors of infants.
    Tahta A; Akalan N
    Childs Nerv Syst; 2023 Feb; 39(2):369-377. PubMed ID: 36607388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma.
    Ingrisch M; Schneider MJ; Nörenberg D; Negrao de Figueiredo G; Maier-Hein K; Suchorska B; Schüller U; Albert N; Brückmann H; Reiser M; Tonn JC; Ertl-Wagner B
    Invest Radiol; 2017 Jun; 52(6):360-366. PubMed ID: 28079702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.
    Clay V; Papaxoinis G; Sanderson B; Valle JW; Howell M; Lamarca A; Krysiak P; Bishop P; Nonaka D; Mansoor W
    Clin Transl Oncol; 2017 May; 19(5):579-586. PubMed ID: 27848218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association Between Tumor Compartment Volumes, the Incidence of Pretreatment Seizures, and Statin-Mediated Protective Effects in Glioblastoma.
    Henker C; Kriesen T; Scherer M; Glass Ä; von Deimling A; Bendszus M; Weber MA; Herold-Mende C; Unterberg A; Piek J
    Neurosurgery; 2019 Oct; 85(4):E722-E729. PubMed ID: 30888031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. No prognostic impact of survivin expression in glioblastoma.
    Preusser M; Gelpi E; Matej R; Marosi C; Dieckmann K; Rössler K; Budka H; Hainfellner JA
    Acta Neuropathol; 2005 May; 109(5):534-8. PubMed ID: 15843906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High Jagged1 expression is associated with poor outcome in primary glioblastoma.
    Qiu XX; Wang CH; You N; Chen BJ; Wang XF; Chen YP; Lin ZX
    Med Oncol; 2015 Jan; 32(1):341. PubMed ID: 25424769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
    Kordek R; Biernat W; Alwasiak J; Liberski PP
    Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infarct volume after glioblastoma surgery as an independent prognostic factor.
    Bette S; Wiestler B; Kaesmacher J; Huber T; Gerhardt J; Barz M; Delbridge C; Ryang YM; Ringel F; Zimmer C; Meyer B; Boeckh-Behrens T; Kirschke JS; Gempt J
    Oncotarget; 2016 Sep; 7(38):61945-61954. PubMed ID: 27566556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of Preoperative Von Willebrand Factor with Magnetic Resonance Imaging Perfusion and Permeability Parameters as Predictors of Prognosis in Glioblastoma.
    Navone SE; Doniselli FM; Summers P; Guarnaccia L; Rampini P; Locatelli M; Campanella R; Marfia G; Costa A
    World Neurosurg; 2019 Feb; 122():e226-e234. PubMed ID: 30312827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.